Genpact's Deep Discount and ATS Growth Reinforce BUY Case

What happened

Genpact has seen a 26% rally yet trades at a forward P/E of 9, far below its 10-year average of 17.1, according to a recent Seeking Alpha article. The company's Advanced Technology Solutions (ATS) segment is a key driver, with 24.1% year-over-year revenue growth, reflecting increasing AI-enabled service demand. Management has raised 2026 EPS growth guidance to at least 12%, supported by a strong balance sheet and a 2% dividend yield with double-digit growth potential. The DeepValue master report aligns with this positive view, citing resilient cash generation and a shift toward higher-value Data-Tech-AI work, but cautions that conversion of GenAI pilots and legacy BPO pricing remain risks. Net-net, the stock appears undervalued relative to peers, but investors should monitor execution on AI-led programs before extrapolating recent momentum.

Implication

The article's emphasis on a forward P/E of 9 versus a 10-year average of 17.1 provides a clear valuation gap, suggesting potential for rerating if growth persists. ATS growth of 24.1% YoY and raised EPS guidance to at least 12% in 2026 demonstrate management's confidence in demand for AI-enabled services, but the market may be underappreciating this mix shift. The master report's BUY stance is reinforced by the company's diversified customer base, sticky Digital Operations, and consistent capital returns, which provide downside protection. However, risks remain: the conversion of GenAI pilots to production is not guaranteed, and pricing pressure in legacy BPO could offset gains, making margin expansion uncertain. Investors should treat the recent rally as a potential entry point for a longer-term story, but should monitor quarterly ATS revenue mix and free cash flow trends before adding aggressively.

Thesis delta

The new article reinforces the master report's BUY thesis by providing concrete data on ATS growth (24.1% YoY) and raised 2026 EPS guidance (at least 12%), which supports the expectation of mix shift toward higher-value services. This adds confidence to the undervaluation argument, as the forward P/E of 9 versus a 10-year average of 17.1 suggests a significant rerating opportunity if growth continues. However, the thesis remains unchanged in its core tenets; the article does not alter the key risks around GenAI pilot conversion and legacy BPO pricing.